Immunomodulatory & Targeted Therapies for Glomerular Diseases

Gain insights into targeted biological agents and immunosuppressants tailored for treating glomerular disorders like FSGS and minimal change disease. Learn how personalized immunotherapy is revolutionizing glomerular disease management. Explore advances in monoclonal antibodies, complement inhibitors, and T-cell modulating therapies designed to minimize relapse and preserve renal function. Understand the role of biomarkers in predicting therapeutic response and guiding individualized treatment plans. Delve into clinical trial outcomes evaluating the safety and efficacy of emerging immunomodulators. Discuss strategies for balancing immune suppression with infection risk in long-term disease management.

    Related Conference of Immunomodulatory & Targeted Therapies for Glomerular Diseases

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Immunomodulatory & Targeted Therapies for Glomerular Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in